Guided Therapeutics (GTHP) Current Deferred Tax Assets (2012 - 2016)

Guided Therapeutics' Current Deferred Tax Assets history runs 5 years deep, the most recent figure standing at $795000.0 for Q4 2016.

• In Q4 2016, Current Deferred Tax Assets rose 27.0% year-over-year to $795000.0; the TTM figure through Dec 2016 stood at $795000.0 (up 27.0% YoY), while the FY2016 annual figure was $795000.0, up 27.0% from the prior year.
• Current Deferred Tax Assets came in at $795000.0 for Q4 2016 at Guided Therapeutics, up from $626000.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $795000.0 in Q4 2016 to a low of $277000.0 in Q4 2012.
• A 5-year average of $490200.0 and a median of $466000.0 in 2014 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets grew 3.61% in 2013 and surged 62.37% in 2014, its largest moves.
• Guided Therapeutics' Current Deferred Tax Assets stood at $277000.0 in 2012, then climbed by 3.61% to $287000.0 in 2013, then soared by 62.37% to $466000.0 in 2014, then jumped by 34.33% to $626000.0 in 2015, then gained by 27.0% to $795000.0 in 2016.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $795000.0, $626000.0, and $466000.0 for Q4 2016, Q4 2015, and Q4 2014 respectively.

Peer Comparison